Dr Reddy's posts 33% rise in profit before tax at Rs 766 crore in Q2

The drug major has reported a 26% increase in revenues at Rs 4,801 crore for Q2

Riding on one-off gains, Dr Reddy’s Laboratories (DRL) has reported a 33 per cent jump in profit before tax (PBT) at Rs 766.4 crore for the September quarter (Q2). Its net profit has more than doubled to Rs 1,092.5 crore.

The drug major has reported a 26 per cent increase in revenues at Rs 4,801 crore for Q2 from Rs 3,797.8 crore in the year-ago period despite a flat growth in the US.

The company’s top line growth was largely hinged on Rs 722.9-crore licence fee received towards the sale of its anti-migraine drug to Upsher-Smith Laboratories and the receipt of Rs